BR0114846A - Método para produzir cristais de tipo b de nateglinida substancialmente livres de cristais de tipo h - Google Patents

Método para produzir cristais de tipo b de nateglinida substancialmente livres de cristais de tipo h

Info

Publication number: BR0114846A
Authority: BR; Brazil
Prior art keywords: crystals; type; nateglinide; substantially free; producing nateglinide
Prior art date: 2000-10-24

Application number

BR0114846-0A

Other languages

English (en)

Portuguese (pt)

Inventor

Michito Sumikawa

Makoto Maruo

Kazuo Miyazaki

Shigehiro Nishina

Yukiko Matsuzawa

Original Assignee

Ajinomoto Kk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-24

Filing date

2001-10-23

Publication date

2004-02-25

2001-10-23 Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk

2004-02-25 Publication of BR0114846A publication Critical patent/BR0114846A/pt

Links

239000013078 crystal Substances 0.000 title abstract 8
OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 title abstract 5
229960000698 nateglinide Drugs 0.000 title abstract 5
238000004519 manufacturing process Methods 0.000 title abstract 3
238000006243 chemical reaction Methods 0.000 abstract 1
238000001035 drying Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Crystallography & Structural Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BR0114846-0A 2000-10-24 2001-10-23 Método para produzir cristais de tipo b de nateglinida substancialmente livres de cristais de tipo h BR0114846A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2000324375		2000-10-24
PCT/JP2001/009293 WO2002034713A1 (en)	2000-10-24	2001-10-23	Process for producing b-form nateglinide crystal

Publications (1)

Publication Number	Publication Date
BR0114846A true BR0114846A (pt)	2004-02-25

Family

ID=18801920

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR0114846-0A BR0114846A (pt)	2000-10-24	2001-10-23	Método para produzir cristais de tipo b de nateglinida substancialmente livres de cristais de tipo h

Country Status (18)

Country	Link
US (2)	US20030229249A1 (2)
EP (1)	EP1334964B1 (2)
JP (1)	JP4225057B2 (2)
KR (1)	KR100810930B1 (2)
CN (1)	CN100422143C (2)
AT (1)	ATE370115T1 (2)
AU (1)	AU2001296001A1 (2)
BR (1)	BR0114846A (2)
CA (1)	CA2426745C (2)
CY (1)	CY1106839T1 (2)
DE (1)	DE60130014T2 (2)
DK (1)	DK1334964T3 (2)
ES (1)	ES2288997T3 (2)
MX (1)	MXPA03003575A (2)
PT (1)	PT1334964E (2)
RU (1)	RU2275354C2 (2)
TW (1)	TWI293290B (2)
WO (1)	WO2002034713A1 (2)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20070104953A (ko) *	2000-03-17	2007-10-29	아지노모토 가부시키가이샤	신경 장애용 약제
PT1334962E (pt) *	2000-10-18	2007-10-09	Ajinomoto Kk	''processo de preparação de acilfenilalaninas''
CA2425538C (en) *	2000-10-18	2010-10-12	Ajinomoto Co., Inc.	Methods for producing nateglinide crystals
RU2271805C2 (ru) *	2000-10-24	2006-03-20	Адзиномото Ко., Инк.	Препарат, содержащий натеглинид
ATE429217T1 (de) *	2000-10-24	2009-05-15	Ajinomoto Kk	Nateglinid enthaltende hydrophile arzneimittelpräparate
US7411089B2 (en)	2002-04-15	2008-08-12	Ajinomoto Co., Inc.	Nateglinide crystals
EP2264004A1 (en) *	2002-04-15	2010-12-22	Ajinomoto Co., Inc.	New nateglinide crystals
US6861553B2 (en)	2002-07-03	2005-03-01	Teva Pharmaceuticals Industries Ltd.	Process for preparing nateglinide and intermediates thereof
US7534913B2 (en)	2002-07-18	2009-05-19	Teva Pharmaceutica Industries Ltd.	Crystalline form of nateglinide
EP1467964A1 (en) *	2002-07-18	2004-10-20	Teva Pharmaceutical Industries Limited	Polymorphic forms of nateglinide
US7420084B2 (en)	2002-07-18	2008-09-02	Teva Pharmaceutical Industries Ltd.	Polymorphic forms of nateglinide
US7148376B2 (en)	2002-07-18	2006-12-12	Teva Pharmaceutical Industries Ltd.	Polymorphic forms of nateglinide
US7358390B2 (en)	2002-07-18	2008-04-15	Teva Pharmaceutical Industries Ltd.	Polymorphic forms of nateglinide
DE60310734T2 (de) *	2003-11-26	2007-10-11	A.M.S.A. Anonima Matèrie Sintètiche e Affini S.p.A.	Verfahren zur Herstellung von Nateglinid in der B-Form
KR20070009726A (ko) *	2004-05-07	2007-01-18	테바 파마슈티컬 인더스트리즈 리미티드	나테글리나이드의 다형태
US20070231393A1 (en) *	2004-05-19	2007-10-04	University Of South Carolina	System and Device for Magnetic Drug Targeting with Magnetic Drug Carrier Particles
WO2005113485A2 (en) *	2004-05-20	2005-12-01	Dr. Reddy's Laboratories Ltd.	Stable nateglinide form b compositions
US7425648B2 (en)	2005-01-03	2008-09-16	A.M.S.A. Anonima Materie Sintetiche E. Affini S.P.A.	Process for the preparation of nateglinide, preferably in B-form
EP1891971A4 (en) *	2005-01-31	2010-02-03	Ajinomoto Kk	MEDICAL COMPOSITION USING HYPERGLY CRAB MEDICAMENT TO TREAT OR TREAT GLUCOSE-INTOLERANCE, BORDERLINE DIABETES, INSULIN RESISTANCE AND HYPERINSULINEMIA
WO2007135533A1 (en) *	2006-05-23	2007-11-29	Aurobindo Pharma Limited	Process for preparing nateglinide b-type crystals
KR100837843B1 (ko) *	2006-12-26	2008-06-13	씨제이제일제당 (주)	나테글리나이드 결정형, 그 제조방법, 및 그를 포함하는약제학적 조성물
AU2011266820A1 (en)	2010-06-14	2013-01-24	Cipla Limited	A process for the preparation of nateglinide
US9303038B2 (en)	2011-09-06	2016-04-05	Cellix Bio Private Limited	Compositions and methods for the treatment of epilepsy and neurological diseases
WO2013167985A1 (en)	2012-05-07	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of neurological disorders
WO2013167990A1 (en)	2012-05-07	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of depression
WO2013168021A1 (en)	2012-05-07	2013-11-14	Mahesh Kandula	Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
WO2013167991A1 (en)	2012-05-08	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of metabolic disorders
US9403826B2 (en)	2012-05-08	2016-08-02	Cellix Bio Private Limited	Compositions and methods for the treatment of inflammatory disorders
US9434704B2 (en)	2012-05-08	2016-09-06	Cellix Bio Private Limited	Compositions and methods for the treatment of neurological degenerative disorders
WO2013168025A1 (en)	2012-05-08	2013-11-14	Mahesh Kandula	Compositions and methods for treatment of blood clotting disorders
WO2013168023A1 (en)	2012-05-08	2013-11-14	Mahesh Kandula	Compositions and methods for treatment of parkinson's disease
WO2013167987A1 (en) *	2012-05-08	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of diabetes
WO2013168014A1 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of familial amyloid polyneuropathy
WO2013168004A2 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of fibromyalgia pain
WO2013168012A1 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of respiratory disorders
WO2013168033A1 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for treatment of neurologic diseases
WO2013167997A2 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of metabolic syndrome
WO2013168001A1 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of moderate to severe pain
US9394288B2 (en)	2012-05-10	2016-07-19	Cellix Bio Private Limited	Compositions and methods for the treatment of asthma and allergy
WO2013168000A1 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of severe pain
WO2013167999A2 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of neurologic diseases
US9273061B2 (en)	2012-05-10	2016-03-01	Cellix Bio Private Limited	Compositions and methods for the treatment of chronic pain
WO2013168005A2 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US9233161B2 (en)	2012-05-10	2016-01-12	Cellix Bio Private Limited	Compositions and methods for the treatment of neurological conditions
US9403857B2 (en)	2012-05-10	2016-08-02	Cellix Bio Private Limited	Compositions and methods for the treatment of metabolic syndrome
US9498461B2 (en)	2012-05-23	2016-11-22	Cellix Bio Private Limited	Compositions and methods for the treatment of inflammatory bowel disease
AU2013264820A1 (en)	2012-05-23	2014-11-27	Cellixbio Private Limited	Compositions and methods for treatment of mucositis
US9492409B2 (en)	2012-05-23	2016-11-15	Cellix Bio Private Limited	Compositions and methods for the treatment of local pain
WO2013175344A2 (en)	2012-05-23	2013-11-28	Mahesh Kandula	Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
US9227974B2 (en)	2012-05-23	2016-01-05	Cellex Bio Private Limited	Compositions and methods for the treatment of respiratory disorders
EP2852569B1 (en)	2012-05-23	2020-10-14	Cellixbio Private Limited	Compositions and methods for the treatment of multiple sclerosis
US9108942B1 (en)	2014-11-05	2015-08-18	Mahesh Kandula	Compositions and methods for the treatment of moderate to severe pain
WO2014020480A2 (en)	2012-08-03	2014-02-06	Mahesh Kandula	Compositions and methods for the treatment migraine and neurologic diseases
WO2014037833A2 (en)	2012-09-06	2014-03-13	Mahesh Kandula	Compositions and methods for the treatment inflammation and lipid disorders
CN104364231A (zh)	2012-09-08	2015-02-18	塞利克斯比奥私人有限公司	用于治疗炎症和脂质异常的组合物和方法
US9333187B1 (en)	2013-05-15	2016-05-10	Cellix Bio Private Limited	Compositions and methods for the treatment of inflammatory bowel disease
EP3004049B1 (en)	2013-06-04	2018-09-05	Cellixbio Private Limited	Compositions and methods for the treatment of diabetes and pre-diabetes
US9096537B1 (en)	2014-12-31	2015-08-04	Mahesh Kandula	Compositions and methods for the treatment of mucositis
EP3240779B1 (en)	2014-09-26	2020-10-28	Cellixbio Private Limited	Compositions and methods for the treatment of epilepsy and neurological disorders
JP6698643B2 (ja)	2014-09-29	2020-05-27	セリックスバイオプライヴェートリミテッドＣｅｌｌｉｘＢｉｏＰｒｉｖａｔｅＬｉｍｉｔｅｄ	多発性硬化症の治療のための組成物及び方法
AU2014414316B2 (en)	2014-10-27	2020-04-09	Cellix Bio Private Limited	Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
US9173877B1 (en)	2014-11-05	2015-11-03	Cellix Bio Private Limited	Compositions and methods for the treatment of local pain
US9284287B1 (en)	2014-11-05	2016-03-15	Cellix Bio Private Limited	Compositions and methods for the suppression of carbonic anhydrase activity
US9175008B1 (en)	2014-11-05	2015-11-03	Cellix Bio Private Limited	Prodrugs of anti-platelet agents
US9150557B1 (en)	2014-11-05	2015-10-06	Cellix Bio Private Limited	Compositions and methods for the treatment of hyperglycemia
US10208014B2 (en)	2014-11-05	2019-02-19	Cellix Bio Private Limited	Compositions and methods for the treatment of neurological disorders
US9321716B1 (en)	2014-11-05	2016-04-26	Cellix Bio Private Limited	Compositions and methods for the treatment of metabolic syndrome
US9290486B1 (en)	2014-11-05	2016-03-22	Cellix Bio Private Limited	Compositions and methods for the treatment of epilepsy
CN104402756B (zh) *	2014-11-27	2016-08-31	天方药业有限公司	一种高纯度那格列奈的制备方法
US9932294B2 (en)	2014-12-01	2018-04-03	Cellix Bio Private Limited	Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en)	2014-12-17	2015-12-08	Cellix Bio Private Limited	Compositions and methods for the treatment of neurological diseases
CA2973178C (en)	2015-01-06	2022-11-01	Cellix Bio Private Limited	Bupivacaine derivatives and their use in the treatment of inflammation and pain
CN109369443A (zh) *	2018-11-05	2019-02-22	扬子江药业集团江苏海慈生物药业有限公司	一种新的那格列奈h晶型的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6354321A (ja) *	1985-03-27	1988-03-08	Ajinomoto Co Inc	血糖降下剤
AU615966B2 (en) *	1987-12-04	1991-10-17	Takeda Chemical Industries Ltd.	Crystals of cephem hydrochloride
DE10199058I2 (de)	1991-07-30	2006-04-27	Alcm Co	Kristalle von N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanin und Verfahren zu ihrer Herstellung
US5463116A (en)	1991-07-30	1995-10-31	Ajinomoto Co., Inc.	Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
AU718350B2 (en) *	1996-11-15	2000-04-13	Ajinomoto Co., Inc.	Tablet composition
US6844006B1 (en) *	1999-07-09	2005-01-18	Pennfield Oil Company	Process and apparatus for the preparation of chlortetracycline-containing animal feed compositions
CZ20022294A3 (cs) *	1999-12-28	2002-11-13	Ajinomoto Co., Inc.	Antidiabetický preparát k orálnímu uľití
KR20070104953A (ko) *	2000-03-17	2007-10-29	아지노모토 가부시키가이샤	신경 장애용 약제
CA2425538C (en) *	2000-10-18	2010-10-12	Ajinomoto Co., Inc.	Methods for producing nateglinide crystals
PT1334962E (pt) *	2000-10-18	2007-10-09	Ajinomoto Kk	''processo de preparação de acilfenilalaninas''
RU2271805C2 (ru) *	2000-10-24	2006-03-20	Адзиномото Ко., Инк.	Препарат, содержащий натеглинид
US7411089B2 (en)	2002-04-15	2008-08-12	Ajinomoto Co., Inc.	Nateglinide crystals

2001
- 2001-10-23 CA CA002426745A patent/CA2426745C/en not_active Expired - Fee Related
- 2001-10-23 PT PT01976819T patent/PT1334964E/pt unknown
- 2001-10-23 JP JP2002537707A patent/JP4225057B2/ja not_active Expired - Fee Related
- 2001-10-23 RU RU2003111948/04A patent/RU2275354C2/ru not_active IP Right Cessation
- 2001-10-23 AT AT01976819T patent/ATE370115T1/de active
- 2001-10-23 WO PCT/JP2001/009293 patent/WO2002034713A1/ja not_active Ceased
- 2001-10-23 MX MXPA03003575A patent/MXPA03003575A/es active IP Right Grant
- 2001-10-23 CN CNB018212999A patent/CN100422143C/zh not_active Expired - Fee Related
- 2001-10-23 DK DK01976819T patent/DK1334964T3/da active
- 2001-10-23 AU AU2001296001A patent/AU2001296001A1/en not_active Abandoned
- 2001-10-23 KR KR1020037005671A patent/KR100810930B1/ko not_active Expired - Fee Related
- 2001-10-23 EP EP01976819A patent/EP1334964B1/en not_active Expired - Lifetime
- 2001-10-23 ES ES01976819T patent/ES2288997T3/es not_active Expired - Lifetime
- 2001-10-23 BR BR0114846-0A patent/BR0114846A/pt not_active IP Right Cessation
- 2001-10-23 DE DE60130014T patent/DE60130014T2/de not_active Expired - Lifetime
- 2001-10-24 TW TW090126305A patent/TWI293290B/zh not_active IP Right Cessation
2003
- 2003-04-24 US US10/421,888 patent/US20030229249A1/en not_active Abandoned
2007
- 2007-06-04 US US11/757,769 patent/US7544834B2/en not_active Expired - Fee Related
- 2007-08-28 CY CY20071101136T patent/CY1106839T1/el unknown

Also Published As

Publication number	Publication date
RU2275354C2 (ru)	2006-04-27
DK1334964T3 (da)	2007-09-24
CY1106839T1 (el)	2012-05-23
EP1334964A1 (en)	2003-08-13
KR20030059212A (ko)	2003-07-07
ATE370115T1 (de)	2007-09-15
EP1334964B1 (en)	2007-08-15
PT1334964E (pt)	2007-09-20
WO2002034713A1 (en)	2002-05-02
MXPA03003575A (es)	2003-07-14
US20070232829A1 (en)	2007-10-04
TWI293290B (2)	2008-02-11
CA2426745C (en)	2009-09-15
JPWO2002034713A1 (ja)	2004-03-04
DE60130014D1 (de)	2007-09-27
US20030229249A1 (en)	2003-12-11
CN100422143C (zh)	2008-10-01
ES2288997T3 (es)	2008-02-01
KR100810930B1 (ko)	2008-03-10
CA2426745A1 (en)	2003-04-23
JP4225057B2 (ja)	2009-02-18
EP1334964A4 (en)	2005-09-28
CN1483018A (zh)	2004-03-17
AU2001296001A1 (en)	2002-05-06
DE60130014T2 (de)	2008-05-08
US7544834B2 (en)	2009-06-09

Legal Events

Date	Code	Title	Description
2010-09-21	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2011-06-14	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2013-10-08	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2014-08-05	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: PAGAR RESTAURACAO.
2014-09-23	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2015-03-24	B08H	Application fees: decision cancelled [chapter 8.8 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 NA RPI 2274 DE 05/08/2014
2015-03-31	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 13A ANUIDADE
2015-08-04	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015.

Publication	Publication Date	Title
BR0114846A (pt)	2004-02-25	Método para produzir cristais de tipo b de nateglinida substancialmente livres de cristais de tipo h
BR0008050A (pt)	2001-10-30	Processo e dispositivo para filtração emcontracorrente
BR0008236A (pt)	2001-12-04	Processo de remoção de biofilmes das superfìciessubmersas em um sistema de águas impuras
RU2003111948A (ru)	2004-09-20	Способы получения кристаллов в-типа натеглинида
BR9711861A (pt)	1999-08-24	Processo para a fabrica-Æo de uma composi-Æo detergente por um processo sem a utiliza-Æo de torre
BR0310005A (pt)	2005-02-15	Método para a produção de ácido orgânico
BR0005488A (pt)	2001-08-07	Processo para a preparação de carbonato de vinileno, e o uso do mesmo
CA2291359A1 (en)	2000-06-01	Electrolytic solution for electrolytic capacitor and electrolytic capacitor using the same
BR0303196A (pt)	2004-06-29	Suporte de montagem de uma extremidade frontal de um veìculo automotor e processo para a fixação destacável de um módulo de refrigeração em um suporte de montagem de uma extremidade frontal
BR9809628A (pt)	2000-07-04	Processos para preparação de um composto e para a preparação de um aminoálcool.
CO5200765A1 (es)	2002-09-27	Nuevos androgenos oralmente activos que son derivados de delta 14 nandrolona 7 alfa - sustituidos
BRPI0400375A (pt)	2005-01-04	Processo para remover vìrus em soluções de fibrinogênio para aplicação terapêutica e fibrinogênio obtido pelo dito processo
DE50101929D1 (de)	2004-05-13	Dermales applikationssystem für aminolävulinsäure
AR048279A1 (es)	2006-04-19	La forma ii cristalina de cabergolina
EP1636176A4 (en)	2010-03-31	POLYMORPHIC FORM A OF 4 -6-ACETYL-3-¬3- (4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO) PROPOXY-2-PROPYLPHENOXY BUTTERIC ACID
BR0108912A (pt)	2002-12-24	Processamento de material por expansão-contração de solvente repetido
BR0312604A (pt)	2005-04-19	ácidos imido-alcanpercarboxìlicos, composições, e, processo para a preparação e uso de ácidos imido-alcanpercarboxìlicos
BRPI0414877A (pt)	2006-11-21	processo e dispositivo para alterar o comportamento de vibraçao de um sistema de motor
BR9909029A (pt)	2000-12-05	Estabilização de poliisocianatos orgânicos
BR0112820A (pt)	2005-06-07	Processo para a preparação de (alfa) clorocetonas
BR0208513A (pt)	2004-10-26	Processo de preparação de benazepril
AR034084A1 (es)	2004-01-21	Proceso para la remocion de dimetil eter en la sintesis de sevoflurano.
RU2003133471A (ru)	2005-05-10	Выращенный монокристалл фторида кальция
BR9811650A (pt)	2000-08-08	Processos para purificação e recuperação de n- (3,3-dimetil-butil)-alfa-l-aspartil-l-fenil-alamina metil-éster, e, n-(3,3-dimetil-butil)-alfa-l-aspartil-l-fenil-alamina metil-éster
ES2135827T3 (es)	1999-11-01	Procedimiento para la obtencion de 3-cloro-3'-nitro-4'-metoxibenzofenona.